During the past decade, Centre de Recherches Medicales de Lambarene conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de Recherches Medicales de Lambarene" #1 sponsor was "Centre de Recherche Médicale de Lambaréné" with 4 trials, followed by "Barcelona Institute for Global Health" with 2 trials sponsored, "Baylor College of Medicine" with 2 trials sponsored, "Prof. Ayola Akim ADEGNIKA" with 1 trials sponsored and "Sanaria Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Recherches Medicales de Lambarene" #1 collaborator was "Centre de Recherche Médicale de Lambaréné" with 5 trials as a collaborator, "Bernhard Nocht Institute for Tropical Medicine" with 3 trials as a collaborator, "Universität Tübingen" with 3 trials as a collaborator, "Centro de Investigação em Saúde de Manhiça" with 2 trials as a collaborator and "Leiden University Medical Center" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Recherches Medicales de Lambarene" are "Hookworm Disease" (2 trials), "Hookworm Infection" (2 trials), "Malaria" (2 trials), "Breakthrough Infection" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Centre de Recherches Medicales de Lambarene" in a lesser frequency.

Most popular intervention types in "Centre de Recherches Medicales de Lambarene" are "Biological" (5 trials), "Drug" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Artefenomel-Ferroquine" (1 trials), "Artemether-Lumefantrine" (1 trials), "Artesunate-Pyronaridine" (1 trials), "BCG SII" (1 trials) and "Benzyl Benzoate 25% Topical Application Lotion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Recherches Medicales de Lambarene" are 9 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Centre de Recherches Medicales de Lambarene". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centre de Recherches Medicales de Lambarene, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Recherches Medicales de Lambarene, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".